BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12609802)

  • 1. [Tissue microarrays a powerful tool in transfer and quality control in oncology].
    Jacquemier J; Ginestier C; Bertucci F; Jauffret EC; Geneix J; Birnbaum D
    Bull Cancer; 2003 Jan; 90(1):31-8. PubMed ID: 12609802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Small but high throughput: how "tissue-microarrays" became a favorite tool for pathologists and scientists].
    Jacquemier J; Ginestier C; Charafe-Jauffret E; Bertucci F; Bege T; Geneix J; Birnbaum D
    Ann Pathol; 2003 Dec; 23(6):623-32. PubMed ID: 15094604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies.
    Bubendorf L; Nocito A; Moch H; Sauter G
    J Pathol; 2001 Sep; 195(1):72-9. PubMed ID: 11568893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tissue array technology for translational research. From gene discovery to application].
    Kim WH
    Exp Mol Med; 2001 Apr; 33(1 Suppl):135-48. PubMed ID: 11708321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of novel gene expression in paraffin-embedded tissues by isotopic in situ hybridization in tissue microarrays.
    Frantz GD; Pham TQ; Peale FV; Hillan KJ
    J Pathol; 2001 Sep; 195(1):87-96. PubMed ID: 11568895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue microarray technology: principles, pitfalls and perspectives--lessons learned from hematological malignancies.
    Tzankov A; Went P; Zimpfer A; Dirnhofer S
    Exp Gerontol; 2005; 40(8-9):737-44. PubMed ID: 16125349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression analysis of mRNA in formalin-fixed, paraffin-embedded archival tissues by mRNA in situ hybridization.
    Henke RT; Eun Kim S; Maitra A; Paik S; Wellstein A
    Methods; 2006 Apr; 38(4):253-62. PubMed ID: 16513366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
    Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
    Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue microarrays in clinical oncology.
    Voduc D; Kenney C; Nielsen TO
    Semin Radiat Oncol; 2008 Apr; 18(2):89-97. PubMed ID: 18314063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HER-2/neu analysis in breast cancer bone metastases.
    Zustin J; Boddin K; Tsourlakis MC; Burandt E; Mirlacher M; Jaenicke F; Izbicki J; Ruether W; Rueger JM; Bokemeyer C; Simon R; Sauter G
    J Clin Pathol; 2009 Jun; 62(6):542-6. PubMed ID: 19474354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue microarrays.
    Dancau AM; Simon R; Mirlacher M; Sauter G
    Methods Mol Biol; 2010; 576():49-60. PubMed ID: 19882257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frozen tumor tissue microarray technology for analysis of tumor RNA, DNA, and proteins.
    Schoenberg Fejzo M; Slamon DJ
    Am J Pathol; 2001 Nov; 159(5):1645-50. PubMed ID: 11696425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue microarrays: a current medical research tool.
    Shergill IS; Shergill NK; Arya M; Patel HR
    Curr Med Res Opin; 2004 May; 20(5):707-12. PubMed ID: 15140337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Array comparative genomic hybridization copy number profiling: a new tool for translational research in solid malignancies.
    Costa JL; Meijer G; Ylstra B; Caldas C
    Semin Radiat Oncol; 2008 Apr; 18(2):98-104. PubMed ID: 18314064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue microarrays: a practical guide.
    Kumar B; De Silva M; Venter DJ; Armes JE
    Pathology; 2004 Aug; 36(4):295-300. PubMed ID: 15370126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of HER-2/neu oncogene status in breast tumors on tissue microarrays.
    Zhang D; Salto-Tellez M; Do E; Putti TC; Koay ES
    Hum Pathol; 2003 Apr; 34(4):362-8. PubMed ID: 12733117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue microarray technology in the routine assessment of HER-2 status in invasive breast cancer: a prospective study of the use of immunohistochemistry and fluorescence in situ hybridization.
    Graham AD; Faratian D; Rae F; Thomas JS
    Histopathology; 2008 Jun; 52(7):847-55. PubMed ID: 18494613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue microarrays: applications in genomic research.
    Watanabe A; Cornelison R; Hostetter G
    Expert Rev Mol Diagn; 2005 Mar; 5(2):171-81. PubMed ID: 15833047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of a novel and low cost technique to construct paraffin tissue microarrays out of paraffinised needle biopsy specimens from patients with breast cancer.
    Vogel UF; Bültmann B
    J Clin Pathol; 2010 Jul; 63(7):640-3. PubMed ID: 20591915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, construction, and use of tissue microarrays.
    Hewitt SM
    Methods Mol Biol; 2004; 264():61-72. PubMed ID: 15020780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.